Home LiteratureArticle Details
PMID: 15122515 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS.

The Journal of infectious diseases ·Vol. 189 ·No. 10 ·2004-05-15 ·Pages 1793-801

Blattner WA, Oursler KA, Cleghorn F, Charurat M, Sill A, Bartholomew C, Jack N, O'Brien T, Edwards J, Tomaras G, Weinhold K, Greenberg M

Abstract

Our objective was to define early virologic and immunologic determinants of human immunodeficiency virus (HIV) type 1 disease progression among 22 case subjects with acute infection from the Trinidad Seroconvertor Cohort. A linear segmented regression model was fitted to sequential quantitative virus load measurements. Parameters of virus kinetics during different phases of primary infection were correlated with clinical and immunologic end points, by use of Kaplan-Meier estimates and Cox regression. Ten individuals developed acquired immunodeficiency syndrome (AIDS)-defining events. In univariate analysis, progression to AIDS was associated with rate of initial HIV clearance (P=.002), virus load during set point (P=.008), and CD4(+) cell count during steady state (P=.04). In the multivariate analysis, a rapid rate of initial clearance was the sole independent predictor of subsequent progression to AIDS and was associated with a 92% reduction in the risk of AIDS. The rate of initial clearance is inversely correlated with the number of early symptoms (r=-0.66; P=.0008). However, symptoms did not predict subsequent risk of AIDS. Among a subset of patients, rapid clearance of plasma HIV-1 after peak viremia is associated with lower viral set point, prolonged virus suppression before loss of virologic control, and decreased risk of AIDS. These findings are consistent with the hypothesis that effective immune responses during the earliest phase of infection are important determinants of the subsequent natural history.

MeSH Terms
Acquired Immunodeficiency Syndrome/virology Adult Antibodies, Viral/blood CD4 Lymphocyte Count Cohort Studies Disease Progression Enzyme-Linked Immunosorbent Assay Female HIV Core Protein p24/blood HIV Infections/virology HIV-1/physiology Humans Kinetics Longitudinal Studies Male Proportional Hazards Models Prospective Studies RNA, Viral/blood,chemistry,genetics Reverse Transcriptase Polymerase Chain Reaction
Chemicals
Antibodies, Viral HIV Core Protein p24 RNA, Viral
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Blattner William A
Institute of Human Virology, University of Maryland, Baltimore, Maryland, USA. blattner@umbi.umd.edu
Oursler Kris Ann
Cleghorn Farley
Charurat Manhattan
Sill Anne
Bartholomew Courtenay
Jack Noreen
O'Brien Thomas
Edwards Jeffrey
Tomaras Georgia
Weinhold Kent
Greenberg Michael
Article Info
Journal
The Journal of infectious diseases
Abbr.
J Infect Dis
ISSN
0022-1899
Published
2004-05-15
Epub
2004-00-26
Pages
1793-801
Language
English
Region
United States
NLM ID
0413675
Subset
IM
Grants
FIC NIH HHS · 1D43TW007113-01 · United States
PHS HHS · 1P01 A140237-01 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com